Omeros Corp. (3O8)
XDUS
Real-time Data
06:00 AM
Day's Range
16.5052 wk Range
3.48Overview - 3O8 - Omeros Corp.
Key Statistics
Valuation
Enterprise Value
229.48M
P/E (Trailing)
‪-332.99‬
PEG Ratio
‪2.34‬
Price / Book
‪-23.38‬
EV / EBITDA
‪-0.96‬
Profitability
Gross Margin
‪97.20%‬
Return on Assets
‪-1.02%‬
Return on Equity
‪2.76%‬
Ownership
Shares Outstanding
72.08M
Price stats
50-Day Avg
‪14.15‬
200-Day Avg
‪11.03‬
Peers - 3O8 - Omeros Corp.
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 3O8XDUSOmeros Corp.+77.85%52-week change-333.00P/E (Trailing)—Profit Margin
- 0QFXDUSModerna Inc.+85.69%52-week change—P/E (Trailing)—Profit Margin
- 0MEXDUSTwist Bioscience Corporation+84.27%52-week change-112.23P/E (Trailing)‪50.72%‬Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+82.13%52-week change-37.88P/E (Trailing)—Profit Margin
- 2LBXDUSIovance Biotherapeutics Inc.+80.83%52-week change-8.43P/E (Trailing)‪34.27%‬Profit Margin
- 42ZXDUSRevolution Medicines, Inc.+78.13%52-week change-30.44P/E (Trailing)—Profit Margin
- 7BGXDUSOncoinvent ASA+76.57%52-week change-0.06P/E (Trailing)—Profit Margin
Profile Summary - 3O8 - Omeros Corp.
About
Omeros Corp. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company concentrates on immunologic and complement-mediated diseases, along with selected orphan and rare indications affecting inflammation, coagulopathies,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
